A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth G Saag, MD, MSc
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of Massachusetts at Worcester
Worcester, Massachusetts, United States
- New York University
New York, New York, United States
- Jewish Hospital of Cincinnati
Cincinnati, Ohio, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Group Health Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2013
- Primary completion
- 31 Oct 2015
- Completion
- 30 Nov 2016
- Last update posted
- 26 Jun 2018
- Registered enrollment
- 2,684
- Registry id
- NCT01907269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.